Trastuzumab-Induced Hepatotoxicity: A Case Report

• Capturing breast cancers’ copy-number landscape in routine pathology: Exploiting low-resolution, genome-wide sequencing to identify HRD and beyond

  2025 British Journal of Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

  1

  citations
• Clinicopathological and molecular characterization of inflammatory breast cancer, the prospective INFLAME registry study

  2025 npj Breast Cancer article Medicine Breast Lesions and Carcinomas Open access

  4

  citations
• Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]

  2024 ESMO Open article Medicine HER2/EGFR in Cancer Research Open access

  11

  citations
• CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing

  2024 Communications Biology article Medicine Monoclonal and Polyclonal Antibodies Research Open access

  13

  citations
• 89Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study

  2023 Cancers article Medicine Medical Imaging Techniques and Applications Open access

  17

  citations
• Mechanisms driving the immunoregulatory function of cancer cells

  2023 Nature reviews. Cancer review Medicine Cancer Immunotherapy and Biomarkers

  272

  citations
• Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas

  2023 Cancer Medicine article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

  18

  citations
• PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer

  2022 npj Breast Cancer article Medicine HER2/EGFR in Cancer Research Open access

  13

  citations
• Update Breast Cancer 2021 Part 4 – Prevention and Early Stages

  2022 Geburtshilfe und Frauenheilkunde article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access

  7

  citations
• Molecular Characterization of Muellerian Tumors of the Urinary Tract

  2021 Genes article Biochemistry, Genetics and Molecular Biology Chromatin Remodeling and Cancer Open access

  14

  citations
• HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes

  2020 Cancers article Medicine Endometrial and Cervical Cancer Treatments Open access

  103

  citations
• HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging

  2020 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Radiopharmaceutical Chemistry and Applications Open access cited by 3 patents

  111

  citations

12 results